dapsone has been researched along with Acne Inversa in 15 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with PASH syndrome and report about the successful multimodal treatment with infliximab, cyclosporine, and dapsone." | 8.91 | Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone. ( Braun-Falco, M; Goerdt, S; Leverkus, M; Lohse, P; Pfannschmidt, N; Staub, J; Strohal, R, 2015) |
| "To evaluate the efficacy of dapsone in the treatment of hidradenitis suppurativa refractory to therapy with oral antibiotics and isotretinoin." | 7.73 | Hidradenitis suppurativa treated with dapsone: A case series of five patients. ( Kaur, MR; Lewis, HM, 2006) |
| "Dapsone was prescribed at doses of 50-150 mg/day." | 5.62 | Dapsone in hidradenitis suppurativa: A case series of 56 patients. ( Gamissans, M; López-Llunell, C; Riera-Martí, N; Romaní, J, 2021) |
| "Reactive arthritis is associated with chronic infections, such as HS, although joint involvement is uncommon." | 5.62 | Dapsone as an Effective Treatment for Arthritis Secondary to Hidradenitis Suppurativa. ( Smith, H; Timofte, I, 2021) |
| "Rapid recurrence after stopping treatment however suggests that anti-inflammatory effects may predominate." | 5.37 | Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. ( Boer, J; Ingvarsson, G; Jemec, GB; Szepietowski, JC; Yazdanyar, S, 2011) |
| "We report its successful use in acne inversa." | 5.31 | [Acne inversa: a dapsone-sensitive dermatosis]. ( Hofer, T; Itin, PH, 2001) |
| "We describe a patient with PASH syndrome and report about the successful multimodal treatment with infliximab, cyclosporine, and dapsone." | 4.91 | Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone. ( Braun-Falco, M; Goerdt, S; Leverkus, M; Lohse, P; Pfannschmidt, N; Staub, J; Strohal, R, 2015) |
| "We present a case of fever, brain abscesses, and Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha (TNF-α) therapy in a 21-year-old acne inversa patient currently taking long-term dapsone." | 3.78 | Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy. ( Asboth, F; Gattringer, KB; Graninger, W; Khalifeh, N; Koreny, M; Lagler, H; Mallouhi, A; Spertini, V; Thalhammer, F; Volc-Platzer, B; Vossen, MG; Willeit, M, 2012) |
| "To evaluate the efficacy of dapsone in the treatment of hidradenitis suppurativa refractory to therapy with oral antibiotics and isotretinoin." | 3.73 | Hidradenitis suppurativa treated with dapsone: A case series of five patients. ( Kaur, MR; Lewis, HM, 2006) |
| "Hidradenitis suppurativa is a common debilitating skin disease that has been neglected by science." | 2.53 | Medical Treatments of Hidradenitis Suppurativa: More Options, Less Evidence. ( Gulliver, WP; van der Zee, HH, 2016) |
| "Although hidradenitis suppurativa is a common and serious skin condition, its treatment is not well established." | 2.52 | Update on Hidradenitis Suppurative (Part II): Treatment. ( García, FJ; Jiménez-Gallo, D; Martorell, A; Pascual, JC; Pereyra-Rodríguez, J; Salgado, L; Villarrasa, E, 2015) |
| "Dapsone was prescribed at doses of 50-150 mg/day." | 1.62 | Dapsone in hidradenitis suppurativa: A case series of 56 patients. ( Gamissans, M; López-Llunell, C; Riera-Martí, N; Romaní, J, 2021) |
| "Reactive arthritis is associated with chronic infections, such as HS, although joint involvement is uncommon." | 1.62 | Dapsone as an Effective Treatment for Arthritis Secondary to Hidradenitis Suppurativa. ( Smith, H; Timofte, I, 2021) |
| "Rapid recurrence after stopping treatment however suggests that anti-inflammatory effects may predominate." | 1.37 | Dapsone therapy for hidradenitis suppurativa: a series of 24 patients. ( Boer, J; Ingvarsson, G; Jemec, GB; Szepietowski, JC; Yazdanyar, S, 2011) |
| "We report its successful use in acne inversa." | 1.31 | [Acne inversa: a dapsone-sensitive dermatosis]. ( Hofer, T; Itin, PH, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 6 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Llunell, C | 1 |
| Riera-Martí, N | 1 |
| Gamissans, M | 1 |
| Romaní, J | 1 |
| Ring, HC | 1 |
| Yao, Y | 1 |
| Maul, JT | 1 |
| Ingram, JR | 1 |
| Frew, JW | 1 |
| Thorsen, J | 1 |
| Nielsen, ML | 1 |
| Wu, JJ | 1 |
| Thyssen, JP | 1 |
| Thomsen, SF | 1 |
| Egeberg, A | 1 |
| Steyn, M | 1 |
| Ayis, S | 1 |
| O'Connor, J | 1 |
| Lakhan, MK | 1 |
| Ferguson, F | 1 |
| Shah, A | 1 |
| Rashidghamat, E | 1 |
| Baroudi, B | 1 |
| Bashyam, AM | 1 |
| Feldman, SR | 1 |
| Pichardo, RO | 1 |
| Murray, G | 1 |
| Hollywood, A | 1 |
| Kirby, B | 1 |
| Hughes, R | 1 |
| Timofte, I | 1 |
| Smith, H | 1 |
| Staub, J | 1 |
| Pfannschmidt, N | 1 |
| Strohal, R | 1 |
| Braun-Falco, M | 1 |
| Lohse, P | 1 |
| Goerdt, S | 1 |
| Leverkus, M | 1 |
| Martorell, A | 1 |
| García, FJ | 1 |
| Jiménez-Gallo, D | 1 |
| Pascual, JC | 1 |
| Pereyra-Rodríguez, J | 1 |
| Salgado, L | 1 |
| Villarrasa, E | 1 |
| van der Zee, HH | 1 |
| Gulliver, WP | 1 |
| Reddick, CL | 1 |
| Singh, MN | 1 |
| Chalmers, RJ | 1 |
| Yazdanyar, S | 1 |
| Boer, J | 1 |
| Ingvarsson, G | 1 |
| Szepietowski, JC | 1 |
| Jemec, GB | 1 |
| Vossen, MG | 1 |
| Gattringer, KB | 1 |
| Khalifeh, N | 1 |
| Koreny, M | 1 |
| Spertini, V | 1 |
| Mallouhi, A | 1 |
| Willeit, M | 1 |
| Volc-Platzer, B | 1 |
| Asboth, F | 1 |
| Graninger, W | 1 |
| Thalhammer, F | 1 |
| Lagler, H | 1 |
| Kozub, P | 1 |
| Simaljakova, M | 1 |
| Kaur, MR | 1 |
| Lewis, HM | 1 |
| Hofer, T | 1 |
| Itin, PH | 1 |
3 reviews available for dapsone and Acne Inversa
| Article | Year |
|---|---|
Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.
Topics: Acne Vulgaris; Anti-Infective Agents; Cyclosporine; Dapsone; Dermatologic Agents; Drug Therapy, Comb | 2015 |
Update on Hidradenitis Suppurative (Part II): Treatment.
Topics: 5-alpha Reductase Inhibitors; Adalimumab; Adrenal Cortex Hormones; Algorithms; Anti-Bacterial Agents | 2015 |
Medical Treatments of Hidradenitis Suppurativa: More Options, Less Evidence.
Topics: Acitretin; Adrenal Cortex Hormones; Anti-Infective Agents; Cyclosporine; Dapsone; Dermatologic Agent | 2016 |
12 other studies available for dapsone and Acne Inversa
| Article | Year |
|---|---|
Dapsone in hidradenitis suppurativa: A case series of 56 patients.
Topics: Adult; Dapsone; Female; Hidradenitis Suppurativa; Humans; Male; Retinoids; Retrospective Studies; Tr | 2021 |
The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study.
Topics: Acitretin; Anti-Bacterial Agents; Biological Factors; Biological Products; Clindamycin; Dapsone; Dic | 2022 |
Dapsone therapy for hidradenitis suppurativa: a retrospective review of characteristics and treatment outcomes in a cohort of 122 patients in a tertiary dermatology setting.
Topics: Dapsone; Dermatology; Hidradenitis Suppurativa; Humans; Retrospective Studies; Treatment Outcome | 2023 |
Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series.
Topics: Adalimumab; Dapsone; Drug-Related Side Effects and Adverse Reactions; Hidradenitis Suppurativa; Huma | 2023 |
Dapsone therapy for hidradenitis suppurativa.
Topics: Dapsone; Hidradenitis Suppurativa; Humans | 2020 |
Dapsone as an Effective Treatment for Arthritis Secondary to Hidradenitis Suppurativa.
Topics: Anti-Bacterial Agents; Arthritis; Dapsone; Hidradenitis Suppurativa; Humans; Treatment Outcome | 2021 |
Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Com | 2010 |
Dapsone therapy for hidradenitis suppurativa: a series of 24 patients.
Topics: Adult; Dapsone; Dermatologic Agents; Female; Glucosephosphate Dehydrogenase; Hidradenitis Suppurativ | 2011 |
Gemella morbillorum bacteremia after anti-tumor necrosis factor alpha as acne inversa therapy.
Topics: Anti-Infective Agents; Antibodies; Bacteremia; Brain Abscess; Dapsone; Gemella; Gram-Positive Bacter | 2012 |
Hidradenitis suppurativa treated with combination of infliximab and dapsone.
Topics: Antibodies, Monoclonal; Dapsone; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Humans | 2012 |
Hidradenitis suppurativa treated with dapsone: A case series of five patients.
Topics: Adult; Aged; Anti-Infective Agents; Dapsone; Female; Hidradenitis Suppurativa; Humans; Male; Middle | 2006 |
[Acne inversa: a dapsone-sensitive dermatosis].
Topics: Acne Vulgaris; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Chronic | 2001 |